E. Sconce

发表

The impact of simvastatin on warfarin disposition and dose requirements

F. Kamali, H. Wynne, A. Daly, 2006, Journal of thrombosis and haemostasis : JTH.

Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin.

F. Kamali, H. Wynne, P. Avery, 2007, Blood.

patients with unexplained variability in response to warfarin Vitamin K supplementation can improve stability of anticoagulation for

F. Kamali, H. Wynne, P. Avery, 2008 .

A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene

F. Kamali, A. Daly, E. Sconce, 2005, Journal of thrombosis and haemostasis : JTH.

Appraisal of current vitamin K dosing algorithms for the reversal of over‐anticoagulation with warfarin: the need for a more tailored dosing regimen

F. Kamali, E. Sconce, 2006, European journal of haematology.

Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation

F. Kamali, H. Wynne, E. Sconce, 2005, Thrombosis and Haemostasis.

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.

Peter Wood, F. Kamali, H. Wynne, 2005, Blood.

APOE genotype makes a small contribution to warfarin dose requirements.

F. Kamali, H. Wynne, A. Daly, 2006, Pharmacogenetics and genomics.

Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study

F. Kamali, H. Wynne, P. Avery, 2008, Journal of thrombosis and haemostasis : JTH.

Vitamin K supplementation during oral anticoagulation: No real cause for concern [2]

F. Kamali, H. Wynne, E. Sconce, 2007 .